/Abstract LB214: A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: Efficacy and safety results from the open-label Phase 2 SCOPE Trial
Citation Map
The articles shown here are a subset.See the full list of articles below.
Citing (0)
Citation Count
Data not found
Cited By (0)
Citation Count